Inventiva S.A. American Depository Shares (IVA)

Price$4.03

Value ScoreF

Growth ScoreD

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-12.30%

Price vs S&P 500 (4W)-30.27%

VGM Score27.34

Market Capitalization$881.91M

All Metrics

Book Value / Share (Quarterly)$1.25

P/TBV (Annual)4.56x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-28.33%

Cash Flow / Share (Quarterly)$-0.50

Price vs S&P 500 (YTD)-18.64%

Net Profit Margin (TTM)-7899.55%

EPS (TTM)$-2.65

10-Day Avg Trading Volume0.67M

EPS Excl Extra (TTM)$-2.65

Revenue Growth (5Y)64.51%

EPS (Annual)$-2.19

ROI (Annual)-67.94%

Net Profit Margin (5Y Avg)-2432.66%

Cash / Share (Quarterly)$0.59

Revenue Growth QoQ (YoY)-99.68%

ROA (Last FY)-141.93%

Revenue Growth TTM (YoY)-51.26%

EBITD / Share (TTM)$-0.85

ROE (5Y Avg)-66.60%

Operating Margin (TTM)-3145.51%

Cash Flow / Share (Annual)$-0.63

P/B Ratio16.76x

P/B Ratio (Quarterly)4.50x

Net Income / Employee (Annual)$-7,061,316

EV / Revenue (TTM)161.20x

Net Interest Coverage (TTM)-0.66x

ROA (TTM)-165.30%

EPS Incl Extra (Annual)$-2.19

Current Ratio (Annual)3.16x

Quick Ratio (Quarterly)3.11x

3-Month Avg Trading Volume0.35M

52-Week Price Return19.05%

Revenue / Employee (TTM)$89,397

Tangible BV / Share (Quarterly)$1.23

P/S Ratio (Annual)170.10x

Asset Turnover (Annual)0.02x

52-Week High$6.20

Operating Margin (5Y Avg)-1301.07%

EPS Excl Extra (Annual)$-2.19

CapEx CAGR (5Y)-3.29%

Tangible BV CAGR (5Y)-5.66%

26-Week Price Return-4.37%

Quick Ratio (Annual)3.11x

13-Week Price Return-31.91%

Total Debt / Equity (Annual)0.76x

Current Ratio (Quarterly)3.16x

Enterprise Value$835.78M

Revenue / Share Growth (5Y)16.89%

Asset Turnover (TTM)0.02x

Book Value / Share Growth (5Y)-22.11%

Revenue / Employee (Annual)$89,397

Pretax Margin (Annual)-7891.26%

Cash / Share (Annual)$0.59

3-Month Return Std Dev64.84%

Net Income / Employee (TTM)$-7,061,316

ROE (Last FY)-119.35%

Net Interest Coverage (Annual)-0.60x

EPS Basic Excl Extra (Annual)$-2.19

Receivables Turnover (TTM)3.52x

Total Debt / Equity (Quarterly)0.76x

EPS Incl Extra (TTM)$-2.65

Receivables Turnover (Annual)3.52x

ROI (TTM)-99.63%

P/S Ratio (TTM)170.10x

Pretax Margin (5Y Avg)-2424.93%

Revenue / Share (Annual)$0.03

Tangible BV / Share (Annual)$1.23

Price vs S&P 500 (52W)-5.32%

Year-to-Date Return-11.28%

5-Day Price Return-16.37%

EPS Normalized (Annual)$-2.19

ROA (5Y Avg)-108.60%

Net Profit Margin (Annual)-7899.55%

Month-to-Date Return-18.32%

Cash Flow / Share (TTM)$-2.16

EBITD / Share (Annual)$-0.85

Operating Margin (Annual)-3145.51%

LT Debt / Equity (Annual)0.56x

ROI (5Y Avg)-54.61%

LT Debt / Equity (Quarterly)0.56x

EPS Basic Excl Extra (TTM)$-2.65

P/TBV (Quarterly)4.56x

P/B Ratio (Annual)4.50x

Pretax Margin (TTM)-7891.26%

Book Value / Share (Annual)$1.25

Price vs S&P 500 (13W)-40.16%

Beta-0.18x

Revenue / Share (TTM)$0.02

ROE (TTM)-145.38%

52-Week Low$2.56

vGradeF

gGradeD

mGradeD

vgmGradeD

Show chart for

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.40

4.44

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
IVAInventiva S.A. American Depository Shares	F	D	D	$4.03
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Inventiva SA is a French biopharmaceutical company developing drug candidates targeting nuclear receptors and epigenetic pathways. Its lead program, lanifibranor, is being advanced for non-alcoholic steatohepatitis (NASH), a disease with no currently approved treatments, representing a significant commercial opportunity. The company maintains a pre-clinical pipeline in oncology, fibrosis, and rare diseases, and generates revenue through research partnerships with major pharmaceutical partners including AbbVie and BI.